A non-invasive cerebral perfusion increasing device including four cuffing pad units and a control unit which is connected to the cuffing pad units and is equipped with a blood pressure sensing module and a compression control module. In the non-invasive cerebral perfusion increasing device each cuffing pad unit respectively includes a compression pad, a compression control member and a blood pressure sensing member. The blood pressure sensing module uses the blood pressure sensing members to sense the systolic blood pressure values of the portions of each of the limbs where they are attached and the compression control module controls the degree of compression of each compression pad by controlling the compression control member to a setting desired by the user based on the sensed blood pressure value, such that the blood flow applied to the limbs is blocked and, indirectly, cerebral perfusion is increased.

Exemplary systems, methods and computer-accessible mediums can be provided that can, for example, receive information related to a detection of a pulse of a patient(s), and increase a pressure using a hardware arrangement to reach a first pressure level corresponding to the pulse no longer being detected. The pressure can be decreased to reach a second pressure level corresponding to the pulse being again detected, and the pressure can be maintained at the second pressure level to facilitate a venipuncture of the patient(s).

Wearable devices can be used to provide therapy to users and/or to monitor various physiological parameters of the user. In some cases, therapy can be triggered automatically based on the monitored physiological parameters reaching or exceeding predefined thresholds.

The present invention relates to a wearable apparatus for continuous monitoring of physiological parameters. The invention relates to the field of physiological parameters monitoring technology. The wearable apparatus for the continuous monitoring of physiological parameters comprises an earring body and a monitoring device; wherein the monitoring device comprises a sensor module, the sensor module being arranged at the earring body for obtaining a biological signal at an auricle; the biological signal is to be inputted to a pre-built physiological system model or a deep machine learning model to obtain a physiological parameter; the physiological parameter comprising tonoarteriogram (TAG) signals. The invention realizes the convenience of wearing by a user without affecting normal activities of the user, further allows performing of a long-term monitoring of the user and improving monitoring accuracy while reducing damages to the skin of the ear.

An example of a system for modulating blood pressure may include a blood pressure monitoring circuit, a blood pressure modulation device, and a control circuit. The blood pressure monitoring circuit may be configured to sense signals and generate one or more blood pressure parameters indicative of the blood pressure and/or a vascular resistance and one or more activity parameters indicative of an activity level and/or a postural change using the sensed signals. The blood pressure modulation device may be configured to deliver a therapy modulating the blood pressure. The control circuit may be configured to control the therapy using therapy parameters, receive the one or more blood pressure parameters and the one or more activity parameters, analyze changes in the one or more blood pressure parameters that are correlated to changes in the one or more activity parameters, and adjust the therapy parameters using an outcome of the analysis.

A mammography apparatus includes a support plate for supporting a breast of a patient, a compression plate movable toward and away from the support plate for compressing the breast against the support plate, and a controller configured to control movement of the compression plate toward and away from the support plate. The controller is configured to adjust at least one of a rate of compression and a pressure applied to the breast based on a measurement of at least one of a diastolic pressure and a systolic pressure of the patient taken during at least one of a compression phase and a clamping phase of the mammography apparatus.

A wearable assembly has a pulse plethysmography (PPG) sensor and a piezoelectric pressure sensor and is attachable to a patient's finger or other area corresponding to a peripheralvascular region, and further includes a signal processor configured to monitor blood flow dependent measurements and pressure measurements over time, comparing these measurements to determine properties of the vascular region, such as vascular resistance of a blood vessel, vascular radius of the blood vessel, vascular stiffness of the vascular region, blood pressure, and/or cardiac vascular power. The signal processor may apply a hysteresis comparison of the sensor outputs, e.g., using an elliptical model, and in some examples may apply an extended Kalman filter for optimizing output of the vascular region properties.

A method is directed to continuously, non-invasively, and directly measuring blood pressure, and includes providing a calibrated measurement device having a blood-flow control balloon and a sensor array. The method further includes placing the sensor array in a non-invasive manner over the surface of a patch of skin connected to an artery by adjoining soft tissues and inflating the blood-flow control balloon with a controlled amount of pressure. In response to the inflating of the blood-flow control balloon, changes in the artery geometry and forces are detected, via the sensor array, during a heartbeat cycle. The changes correspond to spatio-temporal signals from the artery or in the adjoining soft tissues. The spatio-temporal signals are measured and processed, via a controller, to determine blood-pressure parameters.

Systems and methods for blood pressure measurement (BP) based on photoplethysmogram (PPG) data and electrocardiogram (ECG) data an initial baseline BP from a reliable source. A force is cyclically applied to a PPG sensor and the PPG pulse data is recorded and analyzed to determine a PPG-pulse-peak value. The initial baseline MAP is used to configure a MAP model. Additionally, a pre-determined PTT model utilizing PPG and ECG data along blood vessel parameters and baseline BP are initialized to generate a BP. Subsequent BP measurements use the same process of determining PPG-pulse-peak values, the initialize MAP model and pre-determined PTT model to determine a new BP value.

A method for identifying physiological states of a patient includes receiving, by a hemodynamic monitor, sensed hemodynamic data representative of an arterial pressure waveform of the patient; performing, by the hemodynamic monitor, waveform analysis of the hemodynamic data to determine a plurality of profiling parameters; extracting, by the hemodynamic monitor, a patient data segment comprising a patient data set for a first profiling parameter of the plurality of profiling parameters; comparing, by the hemodynamic monitor, the patient data segment to a plurality of stored data segments from a database, each of the plurality of stored data segments having an associated stored discrete state data set indicative of whether a clinical intervention was administered and a stored data set for the first profiling parameter; identifying, by the hemodynamic monitor, a plurality of stored data segments satisfying threshold similarity criteria with respect to the patient data segment; and displaying, by the hemodynamic monitor, a predicted discrete state indicator of the patient.